Table 1.
Incident Primary Melanoma | Prior Primary Melanoma | |
---|---|---|
Characteristic | (n=2387)a | (n=527)a |
Sex | ||
Male | 1322 (55.4) | 354 (67.2) |
Female | 1065 (44.6) | 173 (32.8) |
Age at diagnosis, y | ||
Mean (±SD) | 58.3 ± 16.1 | 65.9 ± 12.9 |
< 50 | 712 (29.8) | 62 (11.8) |
50–69 | 966 (40.5) | 222 (42.1) |
≥ 70 | 709 (29.7) | 243 (46.1) |
Race/Ethnicity | ||
Caucasian | 2380 (99.7) | 526 (99.8) |
Non-Caucasian | 7 (0.3) | 1 (0.2) |
Country | ||
Australia (New South Wales & Tasmania) | 1096 (45.9) | 394 (74.8) |
Canada (British Columbia & Ontario) | 547 (22.9) | 76 (14.4) |
Italy (Torino) | 75 (3.1) | 2 (0.4) |
United States (NC, NJ, MI, and CA) | 669 (28.0) | 55 (10.4) |
Histopathologic pigmentation | ||
Pigmented | 2209 (92.5) | 495 (93.9) |
Amelanotic | 178 (7.5) | 32 (6.1) |
Histologic subtype | ||
Superficial Spreading | 1551 (65.0) | 353 (67.0) |
Nodular | 182 (7.6) | 40 (7.6) |
Lentigo maligna | 286 (12.0) | 87 (16.5) |
In-situ | 161 (6.7) | 0 (0.0) |
Unclassified/otherb | 207 (8.7) | 47 (8.9) |
Anatomic Site | ||
Head, neck | 437 (18.3) | 84 (15.9) |
Trunk, pelvis | 1040 (43.6) | 248 (47.1) |
Upper extremities | 424 (17.8) | 94 (17.8) |
Lower extremities | 486 (20.4) | 101 (19.2) |
Breslow thickness, mmc | (n=2,380) | (n=525) |
Median (IQR), mm | 0.6 (0.8) | 0.7 (0.7) |
In-situ | 167 (7.0) | 0 (0.0) |
0.01 to 1.00 | 1518 (63.8) | 365 (69.5) |
1.01 to 2.00 | 405 (17.0) | 95 (18.1) |
2.01 to 4.00 | 195 (8.2) | 49 (9.3) |
>4.00 | 95 (4.0) | 16 (3.1) |
Abbreviations: GEM = Genes, Environment, and Melanoma; IQR = interquartile range; SD = standard deviation.
Data are given as number (percentage) of melanomas.
Other includes acral lentiginous, spindle cell, nevoid, and Spitzoid melanomas.
Counts do not sum to the total number of study subjects due to missing data.